US Market Traction CLEW has demonstrated healthcare traction in the US with Penn State Health's vICU deployment and a 2024 AvaSure collaboration, signaling readiness to scale with large health systems and telehealth partners.

Capacity ROI Its real-time AI predictions and consolidated clinical view enable faster bed and resource management, offering clear ROI through improved throughput, reduced length of stay, and better utilization of ICU, ED, PACU, and med-surg beds.

Interoperable Platform The platform integrates data from EHRs, bedside monitors, and connected devices, aligning with health systems seeking interoperable solutions that minimize disruption and fit into existing IT ecosystems.

Regulatory Edge FDA-cleared Class II AI predictions provide regulatory credibility and safety assurances, helping procurement teams justify investment and potentially shorten purchasing cycles.

Partnership Opportunities The AvaSure partnership showcases CLEW's ability to co-sell and expand through telehealth and virtual surveillance alliances, suggesting avenues to partner with tele-ICU vendors, remote monitoring platforms, and EHR/health IT integrators.